Skip to main content

Peer Review reports

From: Targeting Ezh2 could overcome docetaxel resistance in prostate cancer cells

Original Submission
19 Mar 2018 Submitted Original manuscript
23 Oct 2018 Author responded Author comments - Xiaofu Qiu
17 Jun 2018 Reviewed Reviewer Report - Supreet Agarwal
8 Sep 2018 Reviewed Reviewer Report - Reviewer 2
Resubmission - Version 2
23 Oct 2018 Submitted Manuscript version 2
11 Nov 2018 Author responded Author comments - Xiaofu Qiu
26 Oct 2018 Reviewed Reviewer Report - Supreet Agarwal
Resubmission - Version 3
11 Nov 2018 Submitted Manuscript version 3
Publishing
16 Dec 2018 Editorially accepted
8 Jan 2019 Article published 10.1186/s12885-018-5228-2

You can find further information about peer review here.

Back to article page